JPMORGAN CHASE & CO - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$60,331,892
-18.5%
3,665,364
-1.0%
0.01%
-12.5%
Q2 2023$73,994,565
-2.3%
3,701,579
-7.6%
0.01%
-11.1%
Q1 2023$75,746,000
+87916.4%
4,005,623
+5.6%
0.01%
-18.2%
Q4 2022$86,059
-99.9%
3,794,477
-6.4%
0.01%
-26.7%
Q3 2022$107,165,000
+2.2%
4,054,655
-4.5%
0.02%0.0%
Q2 2022$104,849,000
-33.1%
4,244,896
-10.2%
0.02%
-21.1%
Q1 2022$156,812,000
-4.2%
4,724,693
-5.6%
0.02%0.0%
Q4 2021$163,656,000
-5.7%
5,004,773
+20.9%
0.02%
-9.5%
Q3 2021$173,562,000
+20.0%
4,140,326
+11.2%
0.02%
+23.5%
Q2 2021$144,594,000
+21.1%
3,721,845
+6.3%
0.02%
+6.2%
Q1 2021$119,415,000
+1.2%
3,500,879
+34.6%
0.02%
-5.9%
Q4 2020$117,998,000
+112.9%
2,601,366
+31.0%
0.02%
+88.9%
Q3 2020$55,433,000
-21.4%
1,986,112
+3.7%
0.01%
-35.7%
Q2 2020$70,550,000
+44.9%
1,915,561
+27.4%
0.01%
+27.3%
Q1 2020$48,679,000
-13.3%
1,503,346
+9.6%
0.01%
+10.0%
Q4 2019$56,176,000
+28.0%
1,371,134
+11.2%
0.01%
+11.1%
Q3 2019$43,878,000
-25.4%
1,232,539
+4.3%
0.01%
-18.2%
Q2 2019$58,787,000
-14.9%
1,182,134
-1.9%
0.01%
-21.4%
Q1 2019$69,085,000
+50.3%
1,205,445
+10.0%
0.01%
+27.3%
Q4 2018$45,968,000
-43.0%
1,095,825
+2.6%
0.01%
-26.7%
Q3 2018$80,629,000
+3.9%
1,067,948
-1.3%
0.02%
-6.2%
Q2 2018$77,633,000
+75.8%
1,082,006
-26.8%
0.02%
+77.8%
Q1 2018$44,151,000
-12.5%
1,479,100
-2.5%
0.01%
-18.2%
Q4 2017$50,437,000
+23.7%
1,516,908
+19.4%
0.01%
+22.2%
Q3 2017$40,778,000
+68.3%
1,270,327
+3.5%
0.01%
+50.0%
Q2 2017$24,230,000
+6.8%
1,226,835
+4.3%
0.01%
+20.0%
Q1 2017$22,693,000
+22.4%
1,175,794
+17.6%
0.01%
+25.0%
Q4 2016$18,546,000
+30.7%
999,747
-1.3%
0.00%
+33.3%
Q3 2016$14,188,000
+449.9%
1,012,666
+213.9%
0.00%
+200.0%
Q2 2016$2,580,000
-27.9%
322,582
-2.6%
0.00%0.0%
Q1 2016$3,579,000
-39.9%
331,340
-7.6%
0.00%0.0%
Q4 2015$5,955,000
+23.7%
358,752
+64.2%
0.00%0.0%
Q3 2015$4,813,000218,4740.00%
Other shareholders
REGENXBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 847,424$13,948,59912.64%
Sonic GP LLC 518,079$8,527,5808.28%
MPM BioImpact LLC 656,718$10,809,5782.89%
Redmile Group, LLC 2,574,042$42,368,7312.02%
ArchPoint Investors 224,278$3,691,6161.41%
WS MANAGEMENT LLLP 618,131$10,174,4360.82%
Redwood Wealth Management Group, LLC 14,360$236,3660.28%
HARBOR CAPITAL ADVISORS, INC. 48,559$799,2810.17%
PRENTISS SMITH & CO INC 11,240$185,0100.14%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 36,522$601,1520.09%
View complete list of REGENXBIO INC shareholders